Phil Skolnick, Chief Scientific Officer at OPIANT PHARMACEUTICALS, INC. (OPNT), sold 17,441 shares at $15.32 ($267K) on 2019-02-01, disclosed to the SEC on 2019-02-04.
Open-market sale of $267k OPNT by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $15.32 | 7,441 | $114K | 42.7% |
| 2 | $15.32 | 7,441 | $114K | 42.7% |
| 3 | $15.31 | 2,559 | $39K | 14.7% |
| Total | $15.32 avg | 17,441 | $267K | 100% |
| Filing → |
| OPNT | SELL | 2023-01-05 | $29K | — | Filing → |
| OPNT | SELL | 2022-07-15 | $7K | — | Filing → |
| OPNT | SELL | 2022-01-27 | $40K | — | Filing → |